Education
About Us
Working with TipRanks
Follow Us
Bayer (BAYRY)
OTHER OTC:BAYRY
BAYRY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.89 - $8.57
Previous CloseN/A
Volume306.92K
Average Volume (3M)135.73K
Market Cap
$32.24B
Enterprise Value$69.36B
Total Cash (Recent Filing)$5.50B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Nov 11, 2025EPS Estimate
0.11Last Dividend Ex-Date
Apr 29, 2025Dividend Yield0.38%
Share Statistics
EPS (TTM)0.36
Shares Outstanding3,929,696,000
10 Day Avg. Volume37,311
30 Day Avg. Volume135,727
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.15
Enterprise Value/Revenue1.50
Enterprise Value/Gross Profit2.73
Enterprise Value/Ebitda10.59
Forecast
1Y Price Target
$7.75Price Target Upside-5.60% Downside
Rating ConsensusHold
Number of Analyst Covering2
Bayer News
BAYRY FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was $4.88 and its highest was $8.57 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is $32.24B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Nov 11, 2025 which is in 70 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Aug 06, 2025. The company reported $0.358 earnings per share for the quarter, beating the consensus estimate of $0.257 by $0.101.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Overvalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of $0.031 which represents an annual dividend yield of 0.38%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 0.11.
How many shares outstanding does Bayer have?
Bayer has 3,929,696,000 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of $0.358 in its last earnings report, beating expectations of $0.257. Following the earnings report the stock price went down -9.476%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in BAYRY
Bayer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.75 (-5.60% Downside)
$7.75 (-5.60% Downside)
Blogger Sentiment
Bullish
BAYRY Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 155.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.4%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.05%
12-Months-Change
Fundamentals
Return on Equity
-10.31%
Trailing 12-Months
Asset Growth
-3.84%
Trailing 12-Months
Company Description
Bayer
Bayer AG is a global life sciences company based in Germany, operating primarily in the sectors of pharmaceuticals, consumer health, and crop science. The company focuses on innovative solutions in healthcare and agriculture, offering a diverse range of products that include prescription medications, over-the-counter products, and agricultural inputs such as seeds and crop protection solutions. Bayer is committed to advancing health and nutrition through scientific research and development, aiming to improve the quality of life for people around the world.
BAYRY Company Deck
BAYRY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed outlook. While the company achieved debt reduction and saw strong performance in its Pharmaceuticals and Consumer Health divisions, significant challenges remain in the Crop Science division with ongoing regulatory and litigation issues. The year 2025 is expected to be challenging, particularly for the Pharmaceuticals division, due to anticipated sales declines and regulatory pressures.View all BAYRY earnings summariesBAYRY Stock 12 Month Forecast
Average Price Target
$7.75
▼(-5.60% Downside)
Technical Analysis
Ownership Overview
―
Insiders
0.17% Mutual Funds
0.17% Other Institutional Investors
99.39% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---